Vyome Biosciences announces top-line results from Phase 1 study of VB-1953 for patients with facial acne vulgaris

Read more

Don’t shut down the pharmacy of the developing world

Read more

Marsh India’s EH&B Survey 2017: Broaden your employee benefits insurance portfolio

Read more

Roche to gain most as Biogen remains leader in neurodegenerative drugs market by 2022

Read more

Pfizer, Novartis and Eli Lilly set to compete in the HER2-/HR+ breast cancer market

Read more

Era of Electroceuticals Coming soon?

Read more

Healthcare Sabha 2017 discusses blueprint for a healthy India

Read more

International Ayurveda Congress

Read more

Second International Ayurveda Congress to be held in London

Read more

IDMA, NSF Health Sciences launch training programme in pharma quality management

Read more